Pilot safety trial of deferiprone in 10 subjects with superficial siderosis

Stroke

Volumn 43, Issue 1, 2012, Pages 120-124

  Levy, Michael ^a   Llinas, Rafael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

deferiprone; hemosiderosis; superficial siderosis

Indexed keywords

DEFERIPRONE; FERRITIN; HEMOSIDERIN;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; LEUKOCYTE COUNT; LIVER FUNCTION; MALE; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; PRIORITY JOURNAL; SIDE EFFECT; SUPERFICIAL SIDEROSIS;

ADULT; AGED; BRAIN; FEMALE; HEMOSIDERIN; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PYRIDONES; SIDEROSIS; TREATMENT OUTCOME;

EID: 84855347130     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.628032     Document Type: Article

References (10)

1. Fearnley JM, Stevens JM, Rudge P. Superficial siderosis of the central nervous system. Brain. 1995;118:1051-1066.
2. Levy M, Turtzo C, Llinas RH. Superficial siderosis: a case report and review of the literature. Nat Clin Pract Neurol. 2007;3:54-58; quiz 59. (Pubitemid 46056034)
3. Kumar N, Lane JI, Piepgras DG. Superficial siderosis: sealing the defect. Neurology. 2009;72:671-673.
4. Koeppen AH, Dentinger MP. Brain hemosiderin and superficial siderosis of the central nervous system. J Neuropathol Exp Neurol. 1988;47: 249-270.
5. Parnes SM, Weaver SA. Superficial siderosis of the central nervous system: a neglected cause of sensorineural hearing loss. Otolaryngol Head Neck Surg. 1992;107:69-77.
6. Levy M, Llinas RH. Deferiprone reduces hemosiderin deposits in the brain of a patient with superficial siderosis. AJNR Am J Neuroradiol. 2011;32:E1-E2.
7. Cohen AR, Galanello R, Piga A, De Sanctis V, Tricta F. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone. Blood. 2003;102:1583-1587. (Pubitemid 37022545)
8. Cohen A, Galanello R, Piga A, Vullo C, Tricta F. A multi-center safety trial of the oral iron chelator deferiprone. Ann N Y Acad Sci. 1998;850: 223-226. (Pubitemid 28369762)
9. Piga A, Gaglioti C, Fogliacco E, Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica. 2003;88: 489-496. (Pubitemid 36648438)
10. Kumar N. Neuroimaging in superficial siderosis: an in-depth look. AJNR Am J Neuroradiol. 2010;31:5-14.